| Apolipoprotein C-III: understanding an emerging cardiovascular risk factor EMM Ooi, PHR Barrett, DC Chan, GF Watts Clinical science 114 (10), 611-624, 2008 | 433 | 2008 |
| Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet DC Chan, GF Watts, SK Gan, EMM Ooi, PHR Barrett Diabetes Care 33 (5), 1134-1139, 2010 | 183 | 2010 |
| Effect of dietary fatty acids on human lipoprotein metabolism: a comprehensive update EMM Ooi, GF Watts, TWK Ng, PHR Barrett Nutrients 7 (6), 4416-4425, 2015 | 157 | 2015 |
| Demystifying the management of hypertriglyceridaemia GF Watts, EMM Ooi, DC Chan Nature reviews Cardiology 10 (11), 648-661, 2013 | 130 | 2013 |
| Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III DT Chan, GK Dogra, AB Irish, EM Ooi, PH Barrett, DC Chan, GF Watts Journal of lipid research 50 (12), 2524-2531, 2009 | 107 | 2009 |
| Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: a nested case‐control study within the Women's … NR Matthan, EM Ooi, L Van Horn, ML Neuhouser, R Woodman, ... Journal of the American Heart Association 3 (4), e000764, 2014 | 96 | 2014 |
| Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease V Deshpande, A Huck, E Ooi, JH Stone, WC Faquin, GP Nielsen Journal of clinical pathology 65 (8), 725-728, 2012 | 93 | 2012 |
| Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-δ agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity EMM Ooi, GF Watts, DL Sprecher, DC Chan, PHR Barrett The Journal of Clinical Endocrinology & Metabolism 96 (10), E1568-E1576, 2011 | 93 | 2011 |
| An ABC of apolipoprotein C‐III: a clinically useful new cardiovascular risk factor? DC Chan, MM Chen, EMM Ooi, GF Watts International journal of clinical practice 62 (5), 799-809, 2008 | 90 | 2008 |
| Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct … TS Khor, EE Alfaro, EMM Ooi, Y Li, A Srivastava, H Fujita, Y Park, ... The American journal of surgical pathology 36 (3), 331-342, 2012 | 86 | 2012 |
| Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein AI kinetics in obese and nonobese men DC Chan, PHR Barrett, EMM Ooi, J Ji, DT Chan, GF Watts The Journal of Clinical Endocrinology & Metabolism 94 (3), 989-997, 2009 | 86 | 2009 |
| Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism? DC Chan, G Lambert, PHR Barrett, KA Rye, EMM Ooi, GF Watts Clinical chemistry 55 (11), 2049-2052, 2009 | 79 | 2009 |
| Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome TWK Ng, EMM Ooi, GF Watts, DC Chan, JM Weir, PJ Meikle, PHR Barrett The Journal of Clinical Endocrinology & Metabolism 99 (11), E2335-E2340, 2014 | 77 | 2014 |
| Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease EMM Ooi, DT Chan, GF Watts, DC Chan, TWK Ng, GK Dogra, AB Irish, ... Journal of Lipid Research 52 (4), 794-800, 2011 | 72 | 2011 |
| High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics J Ji, GF Watts, AG Johnson, DC Chan, EMM Ooi, KA Rye, AP Serone, ... The Journal of Clinical Endocrinology & Metabolism 91 (3), 973-979, 2006 | 66 | 2006 |
| Effects of Extended-Release Niacin on the Postprandial Metabolism of Lp (a) and ApoB-100–Containing Lipoproteins in Statin-Treated Men With Type 2 Diabetes Mellitus EM Ooi, GF Watts, DC Chan, J Pang, VS Tenneti, SJ Hamilton, ... Arteriosclerosis, thrombosis, and vascular biology 35 (12), 2686-2693, 2015 | 65 | 2015 |
| Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin1 N Thongtang, MR Diffenderfer, EMM Ooi, PHR Barrett, SM Turner, NA Le, ... Journal of lipid research 58 (7), 1315-1324, 2017 | 63 | 2017 |
| Dietary fatty acids and lipoprotein metabolism: new insights and updates EMM Ooi, TWK Ng, GF Watts, PHR Barrett Current opinion in lipidology 24 (3), 192-197, 2013 | 63 | 2013 |
| Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein–apolipoprotein B-100 in obesity DC Chan, GF Watts, SK Gan, ATY Wong, EMM Ooi, PHR Barrett Arteriosclerosis, thrombosis, and vascular biology 30 (5), 1043-1050, 2010 | 63 | 2010 |
| The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies EMM Ooi, PHR Barrett, GF Watts International journal of cardiology 168 (3), 1811-1818, 2013 | 62 | 2013 |